Aimei Health Technology Co, LTD 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
Aimei Health Technology Co., Ltd. announced the termination of its business combination with United Hydrogen Group Inc. and faces substantial doubt regarding its ability to continue as a going concern.
NASDAQ
Aimei Health Technology Co., Ltd. reports significant redemptions and a going concern warning as it pushes to finalize its business combination with United Hydrogen Group Inc. by early 2026.
NASDAQ
Aimei Health Technology Co., Ltd. reports significant trust account redemptions and increased deficit, raising substantial doubt about its ability to continue as a going concern.
NASDAQ
Aimei Health Technology Co., Ltd. reports its financial results for the quarter ended March 31, 2025, amidst ongoing efforts to complete a business combination.
NASDAQ
Aimei Health Technology Co., Ltd. reported a net income of $743,510 for the third quarter of 2024, primarily driven by interest earned on investments held in trust, while also progressing towards a planned business combination with United Hydrogen Group.
NASDAQ
Aimei Health Technology Co., Ltd. reported a net income of $1.36 million for the first six months of 2024 and announced a definitive merger agreement with United Hydrogen Group Inc.
NASDAQ
Aimei Health Technology Co., Ltd., a blank check company, reported a net income of $755,500 for the quarter ended March 31, 2024, primarily driven by interest earned on investments held in trust.